Patents Assigned to Universidade Federal de Minas Gerais
  • Process for expression and production of recombinant protein hybrid protein (p24/p17) derived from human immunodeficiency viruses (HIV-1)
    Patent number: 6525173
    Abstract: The present invention describes recombinant p24/p17 hybrid protein derived from the human immunodeficiency virus, their corresponding encoding recombinant DNA molecule and the process of production of the recombinant protein produced through genetic engineering techniques, to be used in diagnosis, vaccination or in research.
    Type: Grant
    Filed: May 12, 1999
    Date of Patent: February 25, 2003
    Assignee: Universidade Federal de Minas Gerais
    Inventors: Paulo Cesar Peregrino Ferreira, Erna Geessien Kroon
  • Method of producing a recombinant non-glycosylated gp90 of equine infectious anemia virus (EIAV), and product thereof
    Patent number: 6444442
    Abstract: The present invention describes recombinant gp90 envelop protein derived from the equine infectious anemia virus, their corresponding encoding recombinant DNA molecule and the process of production of the recombinant protein produced through genetic engineering techniques, to be used in diagnosis, vaccination or in research.
    Type: Grant
    Filed: August 29, 2000
    Date of Patent: September 3, 2002
    Assignee: Universidade Federal de Minas Gerais-UFMG
    Inventors: Paulo C. P. Ferreira, Erna G. Kroon, Jenner K. P. Dos Reis, Isabella B. F. Ferraz, Romulo C. Leite
  • Process for the expression and production of the recombinant growth factor protein (BEGF) derived from BEAN 58058 virus (BEV)
    Patent number: 6436668
    Abstract: The present invention describes recombinant growth factor (BEGF) protein isolated from the virus BeAn58058, their corresponding encoding recombinant DNA molecule and the process of production of the recombinant BEGF protein produced through genetic engineering techniques, to be used in human or veterinarian clinical or in research.
    Type: Grant
    Filed: February 12, 1999
    Date of Patent: August 20, 2002
    Assignee: Universidade Federal de Minas Gerais
    Inventors: Paulo C. P. Ferreira, Erna G. Kroon, Flavio G. da Fonseca
  • Recombinant human beta-CIS interferon
    Patent number: 6323006
    Abstract: The invention provides a new human interferon (IFN)-&bgr; variant cloned from an amniotic cell library, a cDNA encoding it, and processes for its production and purification. The variant, termed interferon beta-cis, differs from previously known hIFN-&bgr; isoforms by the substitution of a Cys residue for the Tyr present at position 60. Recombinant IFN beta-cis exhibits antiviral activity characteristic of IFN-&bgr;.
    Type: Grant
    Filed: July 13, 1999
    Date of Patent: November 27, 2001
    Assignee: Universidade Federal de Minas Gerais
    Inventors: Paulo Cesar Peregrino Ferreira, Erna Geessien Kroon, Romain Rolland Golgher, Claudio Antonio Bonjardim, Alex Fiorini De Carvalho